Athenex Announces Positive Results of Special Stockholder Meeting

November 22, 2022

https://www.globenewswire.com/news-release/2022/11/22/2561034/0/en/Athenex-Announces-Positive-Results-of-Special-Stockholder-Meeting.html

BUFFALO, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the results of its special meeting of stockholders (the “Special Meeting”), held as a virtual meeting on November 22, 2022.

Read more at globenewswire.com

Related news for (ATNX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.